Perzebertinib is an orally active, blood-brain barrier-penetrant, highly selective HER2 tyrosine kinase inhibitor[1]. Perzebertinib is applicable to research related to HER2-positive metastatic breast cancer with brain metastases[1][2].
Molecular Weight:
548.54
CAS Number:
[2414056-31-6]
Formula:
C27H26F2N8O3
Target:
EGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted